129 related articles for article (PubMed ID: 3393001)
1. Sexual function after surgery and combination chemotherapy in men with disseminated nonseminomatous testicular cancer.
Nijman JM; Schraffordt Koops H; Oldhoff J; Kremer J; Sleijfer DT
J Surg Oncol; 1988 Jul; 38(3):182-6. PubMed ID: 3393001
[TBL] [Abstract][Full Text] [Related]
2. Sexual functioning after multimodality treatment for disseminated nonseminomatous testicular germ cell tumor.
van Basten JP; Jonker-Pool G; van Driel MF; Sleijfer DT; Droste JH; van de Wiel HB; Schraffordt Koops H; Molenaar WM; Hoekstra HJ
J Urol; 1997 Oct; 158(4):1411-6. PubMed ID: 9302133
[TBL] [Abstract][Full Text] [Related]
3. Sexual function after bilateral retroperitoneal lymph node dissection for nonseminomatous testicular cancer.
Nijman JM; Schraffordt Koops H; Oldhoff J; Kremer J; Jager S
Arch Androl; 1987; 18(3):255-67. PubMed ID: 3675073
[TBL] [Abstract][Full Text] [Related]
4. [Sexual dysfunction in men treated for testicular cancer].
Rosendal S; Kristensen E; Giraldi AG
Ugeskr Laeger; 2007 Nov; 169(46):3941-6. PubMed ID: 18078644
[TBL] [Abstract][Full Text] [Related]
5. Gonadal function after surgery and chemotherapy in men with stage II and III nonseminomatous testicular tumors.
Nijman JM; Schraffordt Koops H; Kremer J; Sleijfer DT
J Clin Oncol; 1987 Apr; 5(4):651-6. PubMed ID: 3104546
[TBL] [Abstract][Full Text] [Related]
6. Sexual and marital relationships after treatment for nonseminomatous testicular cancer.
Schover LR; von Eschenbach AC
Urology; 1985 Mar; 25(3):251-5. PubMed ID: 4038829
[TBL] [Abstract][Full Text] [Related]
7. [A study of prevention of ejaculatory disturbance after retroperitoneal lymph node dissection in testicular tumor].
Kihara K; Fukui I; Tari K; Oka K; Oshima H
Nihon Hinyokika Gakkai Zasshi; 1988 Dec; 79(12):1982-90. PubMed ID: 3230749
[No Abstract] [Full Text] [Related]
8. Sexual dysfunction in testicular cancer patients subjected to post-chemotherapy retroperitoneal lymph node dissection: a focus beyond ejaculation disorders.
Dimitropoulos K; Karatzas A; Papandreou C; Daliani D; Zachos I; Pisters LL; Tzortzis V
Andrologia; 2016 May; 48(4):425-30. PubMed ID: 26268684
[TBL] [Abstract][Full Text] [Related]
9. Laparoscopic Retroperitoneal Lymph Node Dissection for Clinical Stage I Nonseminomatous Germ Cell Tumors of the Testis: Safety and Efficacy Analyses at a High Volume Center.
Nicolai N; Tarabelloni N; Gasperoni F; Catanzaro M; Stagni S; Torelli T; Tesone A; Bettin L; Necchi A; Giannatempo P; Raggi D; Colecchia M; Piva L; Salvioni R; Paganoni AM; Pizzocaro G; Biasoni D
J Urol; 2018 Mar; 199(3):741-747. PubMed ID: 28964782
[TBL] [Abstract][Full Text] [Related]
10. Sexual dysfunctions in men treated for testicular cancer--secondary publication.
Rosendal S; Kristensen E; Giraldi AG
Dan Med Bull; 2008 Nov; 55(4):211-5. PubMed ID: 19232160
[TBL] [Abstract][Full Text] [Related]
11. Stage II nonseminomatous germ cell tumors of the testis: an analysis of treatment options in patients with low volume retroperitoneal disease.
Socinski MA; Garnick MB; Stomper PC; Fung CY; Richie JP
J Urol; 1988 Dec; 140(6):1437-41. PubMed ID: 2848138
[TBL] [Abstract][Full Text] [Related]
12. The treatment of ejaculation disorders after retroperitoneal lymph node dissection.
Nijman JM; Jager S; Boer PW; Kremer J; Oldhoff J; Koops HS
Cancer; 1982 Dec; 50(12):2967-71. PubMed ID: 7139590
[TBL] [Abstract][Full Text] [Related]
13. Sexual functioning after treatment for testicular cancer: comparison of treatment modalities.
Jonker-Pool G; van Basten JP; Hoekstra HJ; van Driel MF; Sleijfer DT; Koops HS; van de Wiel HB
Cancer; 1997 Aug; 80(3):454-64. PubMed ID: 9241079
[TBL] [Abstract][Full Text] [Related]
14. Post-treatment fertility in patients with testicular cancer. I. Influence of retroperitoneal lymph node dissection on ejaculatory potency.
Fosså SD; Ous S; Abyholm T; Loeb M
Br J Urol; 1985 Apr; 57(2):204-9. PubMed ID: 2580586
[TBL] [Abstract][Full Text] [Related]
15. Chronic pain has a negative impact on sexuality in testis cancer survivors.
Pühse G; Wachsmuth JU; Kemper S; Husstedt IW; Evers S; Kliesch S
J Androl; 2012; 33(5):886-93. PubMed ID: 21474790
[TBL] [Abstract][Full Text] [Related]
16. Retroperitoneal lymph node dissection after chemotherapy.
Winter C; Raman JD; Sheinfeld J; Albers P
BJU Int; 2009 Nov; 104(9 Pt B):1404-12. PubMed ID: 19840021
[TBL] [Abstract][Full Text] [Related]
17. Return of fertility after treatment for nonseminomatous testicular cancer: changing concepts.
Lange PH; Narayan P; Vogelzang NJ; Shafer RB; Kennedy BJ; Fraley EE
J Urol; 1983 Jun; 129(6):1131-5. PubMed ID: 6304357
[TBL] [Abstract][Full Text] [Related]
18. Current concepts about testicular cancer.
van Basten JP; Schrafford Koops H; Sleijfer DT; Pras E; van Driel MF; Hoekstra HJ
Eur J Surg Oncol; 1997 Aug; 23(4):354-60. PubMed ID: 9315068
[TBL] [Abstract][Full Text] [Related]
19. Ejaculatory status and fertility rates after primary retroperitoneal lymph node dissection.
Beck SD; Bey AL; Bihrle R; Foster RS
J Urol; 2010 Nov; 184(5):2078-80. PubMed ID: 20850817
[TBL] [Abstract][Full Text] [Related]
20. [Sexual dysfunctions of patients treated with orchidectmoy, chemotherapy and retroperitoneal lymphadenectomy, need for systematic andrological care?].
Barkatz J; Kleinclauss F; Rigaud J; Bouchot O; Orillard É; Thiery-Vuillemin A; Mouillet G; Kalbacher E; Madec FX
Bull Cancer; 2019 Oct; 106(10):915-922. PubMed ID: 31126677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
